CASP8 and malignant colon neoplasm: In the colon cancer cell line LS174T, the HDAC inhibitors (HDACis) TMP269 and SAHA decreased HDAC7 levels, leading to upregulation of p21 [79], ATF3, and caspase 8 (CASP8) expression and downregulation of BCL2 expression.